Starpharma Holdings

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Starpharma Holdings (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications.

Its underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses.

SPL has two core development programs: VivaGel portfolio and DEP drug delivery.

Contact Details

4-6 Southampton Crescent , ABBOTSFORD VIC 3067
03 8532 2700
www.starpharma.com

Lists and Charts

Share price

Share price

Starpharma Holdings
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Company Share Transactions

  • Company Activity

    Cheryl Maley
    		NEW ROLE: Cheryl Maley, Chief Executive Officer, Managing Director 08 Aug 2024
    		NEW ROLE: Jeff Davies, Non-Executive Director 08 Aug 2024
    		NEW ROLE: Russell Basser, Non-Executive Director 08 Aug 2024
    Lynda Cheng
    		NEW ROLE: Lynda Cheng, Non-Executive Director 18 Mar 2022
    		NEW ROLE: A Eglezos, 25 Nov 2020
    		NEW ROLE: J R Paull, Corporate Affairs 25 Nov 2020
    		NEW ROLE: D J Owen, Vice President-Research 24 Nov 2020
    		NEW ROLE: Richard Hazelton, Non-Executive Director 03 Nov 2020
    Nigel Baade
    		NEW ROLE: Nigel Baade, Chief Financial Officer, Company Secretary since 2013 03 Nov 2020

Related Information

Access to our data for Starpharma Holdings is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Starpharma Holdings is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today